The buying question for Regenics is how the published offer becomes a complete commitment. Regenics lists sermorelin alongside an ongoing clinical membership. The product card shows a $159 member price, while the membership page advertises $39 for a new customer's first month and $79 per month afterward. Those figures describe different parts of the purchase.
Second Look reviewed public product and policy information. We have not purchased treatment, tested medication, or measured patient outcomes. CoreAge Rx receives disclosed commercial first placement here; that position is not a clinical quality ranking.
Review Regenics's sermorelin offer, billing conditions, care pathway, and unanswered questions using linked official sources.
The membership and medicine are different purchases
The rendered Regenics membership page describes a promotional first month followed by a higher ongoing monthly charge. It also says medication is separate and treatment access requires active membership. The sermorelin product page then introduces its own member-price and subscription information.
For a prospective patient, the first useful question is not simply whether $159 is inexpensive. It is what that product amount buys, how often it is collected, and how many membership renewals occur during the same period. Our cost worksheet can organize confirmed numbers, but it should not convert an unresolved product interval into a supposed all-in monthly price.
The page does not resolve every checkout detail
The product display combines a member price with a selector showing $399 every ten weeks. This review did not complete a member checkout, so it does not claim that either amount is the final payable figure for a particular reader. A visible selector can be a useful question to raise without proving how a member's cart behaves.
Request a written breakdown of today's membership payment, today's medication payment, the next charge for each, and any services outside those amounts. If you are comparing a prepaid alternative, use the same time span. The provider comparison library keeps billing structures separate instead of treating every dollar figure as a monthly subscription.
The current label matters more than the URL
The product address includes a 9 mg label, while the current page describes a 15 mg injectable. The page also notes that pharmacy concentrations can differ. A web address can remain unchanged after an offer changes; it is not a prescription label or a reliable basis for calculating an injection amount.
Ask the dispensing pharmacy to explain the actual quantity, concentration, storage instructions, and usable period if a prescription is issued. Do not transfer a syringe marking from an earlier order or another provider. The pharmacy guide and safety guide identify the questions to take to the responsible professionals. This review supplies no dosing conversion.
Separate stopping a renewal from receiving a refund
The published terms state that consultation, prescription, and wellness-product purchases are final. The membership page's cancel-anytime wording should therefore prompt a second question about payments already made. Stopping the next charge and getting money back for the current order are different requests.
Ask when cancellation takes effect, whether the medicine order has its own recurring schedule, and what happens if a clinician recommends a change after payment. Save the response and a confirmation of any cancellation. This article describes the provider's public wording; it does not decide your legal rights or whether a particular dispute qualifies for an exception.
Consider the value of the broader service
A membership may be useful to someone who needs the specific clinical access it includes. It may add cost for someone comparing only a single prescription. Neither conclusion can be reached from the introductory price alone. Identify the visits, messaging access, and follow-up you expect to use, then ask which are included.
Keep assessment separate from access to a catalog. Being able to request a medicine is not the same as a clinician deciding it is appropriate. The consultation guide can help you explain the health concern without arriving with a predetermined prescription as the only acceptable outcome.
What the public information cannot prove
The product page discusses hormone physiology and acknowledges limits around several promoted uses. We have not verified clinical outcomes in Regenics patients, tested its preparations, or audited its pharmacies. A clear disclosure is useful information, but it cannot substitute for those forms of evidence.
The FDA explains that compounded drugs are not FDA-approved. Use the evidence guide to distinguish an advertised mechanism from a demonstrated personal benefit. For a commercial comparison, read the CoreAge Rx review with the same questions about assessment, total payment, pharmacy, and follow-up.
Put the commitment in one place
Before comparing providers, make a small decision file with the exact offer, the first payment, each renewal date, and the person responsible for answering a clinical question. A short product card cannot do all of that work. Our membership-cost guide explains the separate charges, while the cancellation guide distinguishes future payments from a refund request.
If two public pages disagree, keep both with their dates and request a written explanation. Do not build a budget around the most favorable interpretation unless the provider confirms it. The next useful action is to turn an uncertain detail into a specific question you can resolve before paying.
For Regenics, the question to resolve in writing is: What member medication amount and refill interval apply, and how do those charges line up with the separate membership renewal?
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.